Skip to content

Merchavia

  • HOME
  • COMPANY PROFILE
  • LIFE SCIENCE INVESMENTS
  • MEDICAL DISTRIBUTION
  • INVESTOR RELATIONS
  • MEDIA
  • CONTACT
  • HOME
  • COMPANY PROFILE
  • LIFE SCIENCE INVESMENTS
  • MEDICAL DISTRIBUTION
  • INVESTOR RELATIONS
  • MEDIA
  • CONTACT
Read more about the article Publishing an article in European Urology magazine about the final findings in CDX’s clinical trial
pdf1

Publishing an article in European Urology magazine about the final findings in CDX’s clinical trial

  • Post published:19/04/2017
Read more about the article Engaging in a non-binding Memorandum of Understanding to invest in CardiacSense
pdf1

Engaging in a non-binding Memorandum of Understanding to invest in CardiacSense

  • Post published:26/03/2017
Read more about the article The company is examining investing between NIS 1 million and NIS 4 million in each of 1-3 companies in the field of biomed and life sciences
pdf1

The company is examining investing between NIS 1 million and NIS 4 million in each of 1-3 companies in the field of biomed and life sciences

  • Post published:23/01/2017
← Newer Posts

Investor Relations

  • Investors Lobby
  • Company Profile
  • Company Presentation
  • Immediate Reports
  • Financial Reports
  • Investors News
  • News in the Media
  • Management
  • Stock Chart
  • FAQ
  • Mail Alert
  • Contact

© all rights preserve to Merchavia LTD

HOME
COMPANY PROFILE
LIFE SCIENCE INVESMENTS
INVESTOR RELATIONS
Accessibility
CONTACT